Ticker
LEXXCompany Name
LEXARIA BIOSCIENCE CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -9.77M | -1585.78% | $ 615.92K |
3/31/2025 | $ -7.45M | -1416.43% | $ 525.92K |
12/31/2024 | $ -6.57M | -1322.35% | $ 496.92K |
9/30/2024 | $ -5M | -1077.38% | $ 464.28K |
6/30/2024 | $ -4.69M | -1244.28% | $ 376.85K |
3/31/2024 | $ -5.21M | -1349.48% | $ 386K |
12/31/2023 | $ -5.84M | -2116.6% | $ 276.01K |
9/30/2023 | $ -5.91M | -2614.84% | $ 226.21K |
6/30/2023 | $ -5.42M | -1590.63% | $ 340.79K |
3/31/2023 | $ -4.9M | -1410.85% | $ 347.36K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for LEXARIA BIOSCIENCE CORP is calculated as follows: FCF [ $ -2.66M ] / Revenues [ $ 384.54K ]
(=) FCF % [ -692.58% ]
Minimum
Jun 30, 2022
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.87% |
median | 7.4% |
std | 19.48% |